Showing results (111-120 of 148) with videos related to
Sort By:
Pageof 15
British Journal of Cancer|April 28, 2006
Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II studyJ Bennouna, J-L Breton, J-M Tourani, et al.Anticancer Research|January 30, 2003
Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group studyC Christodolou, N Pavlidis, E Samantas, et al.Cancer Investigation|January 1, 1996
Cisplatin and continuous infusion of fluorouracil followed by radiation and weekly carboplatin in the treatment of locally advanced head and neck cancer: a Hellenic Cooperative Oncology Group studyG Fountzilas, P Kosmidis, K S Sridhar, et al.Cancer Investigation|April 12, 2001
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancerE Razis, A M Dimopoulos, D Bafaloukos, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, A M Dimopoulos, C Papadimitriou, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology GroupH Gogas, C Papadimitriou, H P Kalofonos, et al.Anticancer Research|August 5, 2006
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome dataD Mauri, G Pentheroudakis, D Bafaloukos, et al.European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group studyD V Skarlos, G Aravantinos, P Kosmidis, et al.Oncology|September 20, 2002
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trialsC Bacoyiannis, M A Dimopoulos, H P Kalofonos, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 24, 2000
Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinomaN Tsavaris, D Skarlos, C Bacoyiannis, et al.Pageof 15